Klow BPC 157 10mg + GHK-CU 50mg + TB500 10mg + KPV 10mg Strength: 80mg CAS: BPC-157: 137525-51-0 GHK-Cu: 49557-75-7 TB500: 885340-08-9 KPV: 67727-97-3 Chemical Formula: BPC-157: CHNO GHK-CU: CHNOCu TB500: CHNO KPV: CHNO Molecular weight: BPC-157: 1419.556 g/mol GHK-Cu: 401.91 TB-500(TB-4): 889.0 g/mol KPV: 384.48 g/mol Peptide Sequence: BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Pharmacokinetics: Cyanocobalamin is administered intranasally, orally, and parenterally, while hydroxocobalamin is administered only parenterally. Once absorbed, vitamin B12 is highly bound to transcobalamin II, a specific B-globulin carrier protein and is distributed and stored primarily in the liver as coenzyme B12. The bone marrow also stores a significant amount of the absorbed vitamin B12. This vitamin crosses the placenta and is distributed into breast milk. Enterohepatic recirculation conserves systemic stores. The half-life is about 6 days (400 days in the liver). Elimination is primarily through the bile; however, excess cyanocobalamin is excreted unchanged in the urine
This includes GHK-Cu (Copper Tripeptide-1) and its structural analog AHK-Cu (Copper Tripeptide-3), studied more specifically for perifollicular vascularization see our AHK-Cu vs GHK-Cu comparison for the research differences
We seen improvements almost immediately
The peptide did not cause them, but they happened to appear during use
Novel methylcobalamin nasal spray versus intramuscular injection: A randomized, crossover comparative bioavailability study Int J Endocrinol Metab Disord
